Interleukin-22 and Interleukin-18 as Potential Blood Biomarkers in Dupilumab-Treated Atopic Dermatitis - PubMed
3 days ago
- #biomarkers
- #interleukins
- #atopic dermatitis
- Interleukin-22 (IL-22) and Interleukin-18 (IL-18) are studied as potential blood biomarkers for Dupilumab-treated Atopic Dermatitis.
- The research is published with PMID: 41705302 and DOI: 10.1111/all.70248.
- Keywords associated with the study include IL-18, IL-22, atopic dermatitis, biologics, and biomarker.
- The publication discusses grants and funding related to the research.
- Full text sources and additional resources are available through LinkOut.